Abstract-
Introduction
The advancement in technologies in biological science, molecular biology, recombinant DNA technology and protein engineering have equipped human to understand biomolecules at molecular level and refine them as per requirements [1] . These refined molecules have been used significantly in medicine, industrial application and for analytical applications since long time. The protein molecules which essentially used as enzymes have made many revolutions in medical filed and more ever in industry. Enzymes which are basically proteins have enormous capability of catalysis, which have been employed for the treatment of various diseases, optimization of different conventional industrial process and in design of many diagnostic [2, 3] . To achieve following, enzyme must produced in sufficient quantity with intact activity [4] . To meet the demand in industrial sector and medical application different methods were opted for these amazing molecules, more specifically molecular cloning and expression in microbial host systems [5, 6] . The benefits of microbial host systems, they are easy to grow and manipulate as per requirements. Rather than prokaryotic protein, eukaryotic protein exhibits even more complications while expressions in the prokaryotic host system. This is due to codon bias which interferes in process of translation while selecting t-RNA form amino acid pool as difference in codon and lacking of post translational machinery [7, 8] . Recently few host system have been designed to overcome with these complication like Pichia pastoris. An alternative approach to express the eukaryotic protein is codon optimization which needs few universal codons especially designed for the protein from eukaryotic source [9, 10] .
Commercial Demand of recombinant proteins
The commercial application of recombinant proteins is ubiquitous, protein as enzymes in Industrial applications; Food Processing, Detergents, Beverages, Leather processing are few sector which have explored significance of these molecules. The global production of these enzymes is rapidly increasing which needs large scale production of these potent molecules [11 12 13] .
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Invitro Protein Expression Strategy
Protein expression is a natural phenomenon in every living organism to maintain cell viability and physiology [16, 17] . With the developed technologies the natural process has tuned artificially in specific cells known as host expression system. The expression of any gene runs under specific nucleotide sequences which bind RNA polymerase known as promoter sequence [18] . The promoter sequence which provide platform for RNA polymerase can be classify in natural promoter which usually express protein in threshold level while certain promoter which basically isolated from viral origin provides high level expression known as strong promoter [19, 20] .
In case of expression of protein outside the native host one must need a carrier molecule called as plasmid or vector, possess basic requirement for protein translation. These carrier molecules as per their application classified cloning vector system used for only cloning and expression vector system which ment for expression of proteins [21, 22] . The expression vector system essentially contains high strong promoter generally from viral origin. Frequently used promoters in different expression vector system are CMV and T7 which have been isolated from Cauliflower mosaic virus and T7 bacteriophage respectively [23, 24] . The choice of an expression system for the high-level production of recombinant proteins depends on many factors. These include cell growth characteristics, expression levels, intracellular and extracellular expression, and biological activity of the target protein [25] . In addition, the selection of a particular expression system requires a cost down in terms of process, design, and other economic consideration. The combination of recombinant DNA technology and large-scale culture process has enabled recombinant proteins to be produced in massive quantities [26] . High cell density culture techniques for culturing E. coli have been developed to improved productivity and also to provide advantages such as reduced culture volume, enhanced downstream process, reduced wastewater, lower production costs and reduced investment in equipment [27, 28] .
Complications with conventional Expression system
The complications started while the expression studies for eukaryotic proteins in E. coli expression systems during 1980 [29, 30] . The E. coli expression system lacks many codons essentially requires for the expression of eukaryotic protein and also lack post translational modification machinery for biological activity and some other complex proteins containing multiple disulfide bonds [31, 32, 33] . In addition to codon bias and lack of post translational modification machinery, many proteins expressed in E. coli got accumulated intracellular as inactive inclusion bodies [34, 35] . Expressed protein in the form of inclusion bodies further needs protein renaturation and refolding to retain biological activity, all these transformations are often complicated and costly while running denaturation and refolding process [36] .
To tackle these complications attributed by E. coli expressions system number of animal and plant expression system have designed [37, 38] . Though these engineered expression system have made significant contribution for expression of eukaryotic proteins often failed in E. coli system but again failed to design the simple and efficient, high-yield, low-cost methods which can be used for the production of proteins in large amount [39] . Further advancement of technologies especially in protein engineering and recombinant DNA technology led to development of new generation E. coli expression system competent expression of various proteins [40] . These engineered E. coli expression system designed with certain molecule; chaperons, foldases etc allows expressed protein to retain active structure and also helps translocation from cytoplasm to periplasm and subsequently outside of cell [41, 42] .
New Generation Expression system
In order to meet with industrial demand expression of recombinant protein is best method ever opted. This method is not only produce protein in high fold also we easy to manipulate [43] . Many expression host systems were used for production of commercially important enzyme where E. coli BL21 has long history as ideal host. E. coli BL21 (DE3) strains provide reliable expression of many proteins cloned into T7 expression vectors (e.g., pET, pRSET etc) [44, 45] . Though, numbers of recombinant protein expressed successfully in BL 21 (DE3) but over expression could not achieve yet [46] . Even in many cases expression is minimal or no detectable because the recombinant proteins, when expressed, become deleterious or lethal to these standard BL21 strains. Hence to achieve successful expression and over expression led to design of new engineered strains capable of over expression beyond these complications [47] .
Recently, many E. coli strains C41 (DE3), C43 (DE3) and E. coli Rosetta strains have been developed that allow high level of expression to the variety of proteins previously difficult or impossible to express in bacteria E. coli BL21 [48] . These all strains are genetically engineered ensuring following parametersa-An ideal expression system for majority of recombinant protein. b-To overcome toxicity exhibited by protein itself. c-Offers expression for both prokaryotic and eukaryotic proteins (Rosetta). d-Easy to regulate and cost factors.
Escherichia coli BL Series
With the advance technologies in molecule biology led to redesign existing BL21 (DE 3) strain in order to overcome drawback arises for expression of recombinant proteins. BL 41 (DE 3) and BL 43 (DE3) strains have designed for over express protein where strains contain genetic mutations phenotypically selected for conferring toxicity tolerance which blocks expression in conventional host system [49] . The strain C41 (DE3) was derived from BL21 (DE3) [E. coli F-ompT hsdSB (rB-mB-) gal dcm (DE3)]. This strain has been designed with one uncharacterized mutation that prevents cell death associated with expression of many toxic recombinant proteins [50] . Another strain C43 (DE3) was derived from C41 (DE3) by selecting for resistance to a different toxic protein which was not present in C41 (DE3). From the study it was found C43 (DE 3) had shown ability to express a different set of toxic proteins than C41 (DE3) [51] .
Further, neither strain contains any plasmid or antibiotic resistance markers. However, these two strains were found different from each other and from BL21 (DE3) by study based on transfection with a plasmid verification vector, pAVD10. The vector system PAVD10 comprise of uncF gene (it encodes beta-subunit of E. coli ATPase) under the regulation of T7 promoter. Subsequently, this plasmid was found to lethal for BL21 (DE3) and to induced C41 (DE3), but it is tolerated by C43 (DE3) regardless of induction [52, 53] .
Conventionally E.coli BL21 (DE3) strains and genetically engineered E. coli C41 (DE3) and E.coli C43 (DE3) strains for over expression contain Lambda DE3 lysogen, which expresses T7 RNA polymerase from the lacUV5 promoter under IPTG induction. Following strains can be used to express any gene cloned into a plasmid downstream to T7 promoter [54] . While the engineered strains C41 (DE3) and C43 (DE3) for over expression posses Chloramphinicol-resistant plasmid that encodes T7 lysozyme, which is a natural inhibitor of T7 RNA polymerase. These engineered strains which produce T7 lysozyme that suppresses basal expression of T7 RNA polymerase prior to induction, thus providing additional stability for recombinants encoding particularly toxic proteins [55 56 ].
5.2.
Escherichia coli Rosetta Series Codon bias in another major problem often encountered while expressing recombinant protein in many expression host system [57] . During the translation majority of amino acids are encoded by more than one codons, and each organism carries its own bias in the usage of the 61 available amino acid codons. In every cell, the population of t-RNA closely reflects the codons bias of the mRNA population [58] . When the mRNA of heterologous target genes are over expressed in E. coli, differences in codon usage can block translation due to the demand for one or more t-RNAs that may be rare or lacking in that particular population [59] . Insufficient t-RNA pools can lead to translational stalling, premature translation termination, translation frame shifting and amino acid misincorporation [60] .
To overcome with codon bias many attempt have been made by optimizing codons for expression of recombinant protein. Optimization of codons for each host system is not easy, time consuming and much complicated. A novel host system has been designed with universal codons which not only allow expression but also increases expression yield [61] . Rosetta host strains has deigned to fulfill all these requirements and derived from BL21 derivatives designed to enhance the expression of proteins that contain codons rarely used in E. coli [62] . The Rosetta strains supply t-RNAs for the codons AUA, AGG, AGA, CUA, CCC, and GGA on a New Generation Expression Host System-Aiming high for commercial production of recombinant protein www.iosrjournals.org 13 | Page compatible chloramphenicol-resistant plasmid, pRARE. Newly Rosetta strains also supply a seventh rare codons (CGG) in addition to the six found in the original Rosetta strains [63] . By supplying following rare codons, Rosetta strains provide a -universal‖ translation, where translation would otherwise be limited by the codons usage of E. coli. In few Rosetta strains like pLysS and pLacI the rare t-RNA genes are present on the same plasmids that carry the T7 lysozyme and lac repressor genes respectively [64, 65] . Simultaneously, pRIG plasmid transformed into pRARE by incorporating rare E. coli codons leuW and proL t-RNA genes which improve expression level often not present in any of E. coli strains naturally [66] . While plasmid pRARE is capable for encoding t-RNA genes for all of the -problematic‖ rarely used codons encoding Arg, Ile, Gly, Leu and Pro, except for Arg CGA/CGG [67]. The entire rare t-RNA assembly was incorporated to the pLysS and pLacI plasmids which were derived from pACYC184 to construct pLysSRARE and pLacIRARE, respectively [68] . The plasmids were transformed into various strains to create the Rosetta series of expression hosts. These host strains enhance protein expression from target genes containing rare E. coli codons that would otherwise impede translation [69] . Rosetta pLysS and Rosetta-gami-pLysS are two new variant in this series with slight modifications engineered for over expression of eukaryotic proteins [70] .
Commercially available high level expression host system
Lack of natural proteins, which used in many areas like therapeutics, industry and analytical triggered for finding alternative methods for production of these amazing molecules. Commercial demand and industrial application of recombinant proteins led to develop numbers of new host system and majority of them are in use. These new generation host system expressed many essential protein in higher amount. Enormous expression systems are in the commercial market from various producers to achieve desired protein expression. In the following table the most common host expression systems which are in use summarized as- 
Conclusions
The recent increasing demand of various protein molecules in industries and therapeutics triggered development of new technologies to fulfill commercial consumption. Design of high level expression host systems which not only express recombinant protein to bulk but also provide universal system where different types of protein can be produced without any complications. Though these engineered expression systems have made much remarkable contribution in the field of protein expression but still lot of optimization studies needed. The major challenges which need to achieve these systems are ease of handling, universal application and cost of these engineered hosts. If we could achieve these challenges, this will make a new era in the molecular biology regarding commercial production of recombinant proteins.
